Literature DB >> 22492308

Minireview: CRF and Wylie Vale: a story of 41 amino acids and a Texan with grit.

Tracy L Bale1, Alon Chen.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 22492308      PMCID: PMC3359597          DOI: 10.1210/en.2012-1273

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


× No keyword cloud information.
  34 in total

Review 1.  CRF and CRF receptors: role in stress responsivity and other behaviors.

Authors:  Tracy L Bale; Wylie W Vale
Journal:  Annu Rev Pharmacol Toxicol       Date:  2004       Impact factor: 13.820

2.  Synthetic polypeptide antagonists of the hypothalamic luteinizing hormone releasing factor.

Authors:  W Vale; G Grant; J Rivier; M Monahan; M Amoss; R Blackwell; R Burgus; R Guillemin
Journal:  Science       Date:  1972-05-26       Impact factor: 47.728

3.  TRF and thyroid hormones on prolactin secretion by rat anterior pituitary cells in vitro.

Authors:  W Vale; R Blackwell; G Grant; R Guillemin
Journal:  Endocrinology       Date:  1973-07       Impact factor: 4.736

4.  Corticotropin-releasing factor receptor 2 is a tonic suppressor of vascularization.

Authors:  Tracy L Bale; Frank J Giordano; Reed P Hickey; Yan Huang; Anjali K Nath; Kirk L Peterson; Wylie W Vale; Kuo-Fen Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

5.  Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin.

Authors:  W Vale; J Spiess; C Rivier; J Rivier
Journal:  Science       Date:  1981-09-18       Impact factor: 47.728

6.  Corticotropin-releasing factor (CRF): central effects on mean arterial pressure and heart rate in rats.

Authors:  L A Fisher; J Rivier; C Rivier; J Spiess; W Vale; M R Brown
Journal:  Endocrinology       Date:  1982-06       Impact factor: 4.736

7.  Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors.

Authors:  T M Reyes; K Lewis; M H Perrin; K S Kunitake; J Vaughan; C A Arias; J B Hogenesch; J Gulyas; J Rivier; W W Vale; P E Sawchenko
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

8.  Glucocorticoids regulate the expression of the mouse urocortin II gene: a putative connection between the corticotropin-releasing factor receptor pathways.

Authors:  Alon Chen; Joan Vaughan; Wylie W Vale
Journal:  Mol Endocrinol       Date:  2003-05-22

9.  The cardiovascular physiologic actions of urocortin II: acute effects in murine heart failure.

Authors:  Tracy L Bale; Masahiko Hoshijima; Yusu Gu; Nancy Dalton; Keith R Anderson; Kuo-Fen Lee; Jean Rivier; Kenneth R Chien; Wylie W Vale; Kirk L Peterson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-27       Impact factor: 11.205

10.  Selective activation of corticotropin-releasing factor-2 receptors on neurochemically identified neurons in the rat dorsal raphe nucleus reveals dual actions.

Authors:  Luise Pernar; Andre L Curtis; Wylie W Vale; Jean E Rivier; Rita J Valentino
Journal:  J Neurosci       Date:  2004-02-11       Impact factor: 6.167

View more
  12 in total

Review 1.  A users guide to HPA axis research.

Authors:  Robert L Spencer; Terrence Deak
Journal:  Physiol Behav       Date:  2016-11-18

Review 2.  Preclinical evidence implicating corticotropin-releasing factor signaling in ethanol consumption and neuroadaptation.

Authors:  T J Phillips; C Reed; R Pastor
Journal:  Genes Brain Behav       Date:  2015-01       Impact factor: 3.449

3.  Personal Perspectives on Mentoring.

Authors:  Yvette Taché
Journal:  Gastroenterology       Date:  2015-10-26       Impact factor: 22.682

Review 4.  Brain and Gut CRF Signaling: Biological Actions and Role in the Gastrointestinal Tract.

Authors:  Yvette Tache; Muriel Larauche; Pu-Qing Yuan; Mulugeta Million
Journal:  Curr Mol Pharmacol       Date:  2018       Impact factor: 3.339

Review 5.  Corticotrophin-releasing factor 1 activation in the central amygdale and visceral hyperalgesia.

Authors:  Y Taché
Journal:  Neurogastroenterol Motil       Date:  2015-01       Impact factor: 3.598

Review 6.  Neuropeptide systems and new treatments for nicotine addiction.

Authors:  Adriaan W Bruijnzeel
Journal:  Psychopharmacology (Berl)       Date:  2016-12-28       Impact factor: 4.530

Review 7.  The CRF System as a Therapeutic Target for Neuropsychiatric Disorders.

Authors:  Jeff Sanders; Charles Nemeroff
Journal:  Trends Pharmacol Sci       Date:  2016-10-04       Impact factor: 14.819

Review 8.  The physiological roles of placental corticotropin releasing hormone in pregnancy and childbirth.

Authors:  Murray Thomson
Journal:  J Physiol Biochem       Date:  2012-12-29       Impact factor: 4.158

9.  Overexpression of CRF in the BNST diminishes dysphoria but not anxiety-like behavior in nicotine withdrawing rats.

Authors:  Xiaoli Qi; Lidia Guzhva; Zhihui Yang; Marcelo Febo; Zhiying Shan; Kevin K W Wang; Adriaan W Bruijnzeel
Journal:  Eur Neuropsychopharmacol       Date:  2016-07-22       Impact factor: 4.600

Review 10.  Glucocorticoid actions on synapses, circuits, and behavior: implications for the energetics of stress.

Authors:  Brent Myers; Jessica M McKlveen; James P Herman
Journal:  Front Neuroendocrinol       Date:  2013-12-18       Impact factor: 8.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.